Global Influenza Vaccines Market Is Anticipated To Witness Significant Growth Due To Rising Government Initiatives For Supporting Influenza Vaccination And Growing Prevalence Of Influenza
Overview:
Influenza vaccines protect people from getting sick with the flu. They also help reduce the spread of the flu and helps the community in staying healthy. Every year, flu vaccines prevent millions of illnesses and hospitalizations in the United States. They also lower the risk of serious flu complications in people who have certain health conditions.
To produce a flu vaccine, candidate vaccine viruses (CVVs) are selected by the World Health Organization and distributed to manufacturers. These CVVs are inoculated into cultured mammalian cells (instead of eggs). Then, the virus-containing fluid is collected and purified to make a recombinant influenza virus antigen. The recombinant virus is introduced into host cells that are Food and Drug Administration (FDA) qualified to grow the antigen. The recombinant virus delivers genetic instructions to the host cells to rapidly make the flu HA antigen.
Market Dynamics:
Growing business expansion by key players are estimated to augment growth of the global Influenza Vaccines Market during the forecast period. For instance, Seqirus announced that they are building a new biotech manufacturing plant in Australia in November 2020, for providing influenza vaccinations in the country and rest of the world. Moreover, high cost and increasing restriction in vaccine production are anticipated to restrain growth of the global influenza vaccines for market during the forecast period.
Impact of COVID-19:
The first case of COVID-19 infection was recognized in 2019 in China. In 2020, it was declared as a public health emergency by the World Health Organization. COVID-19 is caused by a virus and it mostly affects the lungs and causes difficulty in breathing. The pandemic had significant impact on several sectors globally.
Strict regulations were imposed in many regions for preventing the spread of the virus. These restrictions had a huge impact on many businesses around the world. The pandemic also affected the healthcare sector. Owing to the increasing spread of the virus there was an increased demand for influenza vaccines. This had a positive impact on the growth of the global Influenza Vaccines Market.
Key Takeaways:
The global Influenza Vaccines Market is estimated to witness robust growth, exhibiting CAGR of 4.2 % over the forecast period, due to rising product launches. For instance, Fluzone, a high-dose influenza vaccine was launched by Sanofi in March 2022, for protection against four strains.
North America is anticipated to witness significant growth in the global market for influenza vaccines during the forecast period, due to rising technological advancement in vaccine production facilities and increasing incidences of influenza infection in the U.S.
Key players active in the global Influenza Vaccines Market are EMERGEX VACCINES, GSK plc, OSIVAX, AstraZeneca, Viatris Inc., SINOVAC, Merck & Co., Inc., Pfizer Inc, EMERGENT, Vaxess Technologies Inc, and CSL Limited.
Comments
Post a Comment